MedPath

LUNA-EMG to Enhance Motor Functions in Neurological Disorders

Not Applicable
Recruiting
Conditions
Stroke
Interventions
Device: LUNA-EMG
Registration Number
NCT04716829
Lead Sponsor
University of Liege
Brief Summary

The aim of the present study is to evaluate the effects of training performed with the LUNA-EMG system to enhance motor functions of the upper limb in stroke This is a randomized open-label trial. Patients will be randomized into the intervention group (LUNA-EMG) or in the control group (standard care).

The effect of the training will be measured with the EMG, the upper limb motor function and the quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Adult
  • Having signed the informed consent
Exclusion Criteria
  • Acute pain syndrome
  • Severe cognitive deficits
  • Risk of fracture or unconsolidated fracture
  • Rigid joints (spasticity, severe osteoarthritis and arthritis) or unstable joints
  • Severe ataxia and apraxia
  • Epilepsy
  • Pacemakers and similar implants
  • Insufficient skin conditions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LUNA-EMGLUNA-EMGThe experimental group will receive 30 minutes of training with the LUNA-EMG for 12 weeks.
Primary Outcome Measures
NameTimeMethod
muscular strength in mV12 weeks

muscular strength will be measured with the EMG

Secondary Outcome Measures
NameTimeMethod
Lovett12 weeks

This scale measures muscular strength. The scale ranges from 0 to 5 (the higher the better).

Fugl-Meyer12 weeks

The scale evaluates motor capacities of the upper limb following a stroke. Scores range from 0 to 66 (the higher the better).

Modified Ashworth Scale12 weeks

This scale measures spasticity. The results are scored from 0 to 4 (the higher the more spastic).

Trial Locations

Locations (1)

CNRF

🇧🇪

Tinlot, Liege, Belgium

© Copyright 2025. All Rights Reserved by MedPath